Methodology

At Northeast Biomedical, we follow a structured and proven 7-Phase Product Development Process, embedded within our ISO 13485:2016–certified Quality Management System. This framework is designed to reduce risk, ensure regulatory readiness, and accelerate time to market—while remaining flexible enough to meet the unique needs, risks, and goals of every client.

Our process delivers more than engineering—it offers a complete strategy for navigating the complexities of medical device development. We work side-by-side with our clients to ensure:

  • A clear, actionable management plan
  • Realistic budget and resource planning
  • Access to a multidisciplinary, experienced engineering team
  • A collaborative path from concept through clinical and commercial readiness

By combining strategic planning, engineering expertise, and regulatory insight, we help transform innovative ideas into safe, effective, and commercially viable medical products—delivered with confidence and clarity.

13485-bw

Phase 1: Evaluation

This initial planning phase establishes the foundation for the entire development program. While some clients perform this phase independently, NEB often provides support to ensure strong strategic alignment from the start.

Key activities include:

  • Assessment of customer needs and product vision
  • Rough Order of Magnitude (ROM) budget estimation
  • Preliminary development schedule
  • Identification of key stakeholders and team members
  • Evaluation of core technology and development risks

The outcome of Phase 1 is a well-scoped, strategically aligned plan that ensures readiness for Phase 2.

Phase 2: Feasibility

In this phase, we explore the feasibility of the proposed technology, device, or system. The focus is on investigation, concept generation, and early risk identification.

Key activities include:

  • Brainstorming and concept development workshops
  • Evaluation of design options and functional approaches
  • Preliminary risk analysis with focus on high-risk elements
  • Early prototyping of critical subsystems or features
  • Definition of key attributes to meet marketing and user needs

This phase is critical for ensuring that technical and commercial goals are aligned before moving into formal development.

Phase 3: Alpha Development

Alpha Development marks the first full design cycle based on the data and strategy defined in Phases 1 and 2.

Key activities include:

  • System-level and subsystem design
  • Development of engineering drawings and specifications
  • Initiation of the Design History File (DHF)
  • Performance of a Design Failure Mode and Effects Analysis (DFMEA)
  • Alpha prototype builds for initial form/function testing

This phase culminates in a complete, documented device design ready for refinement and verification.

Phase 4: Beta Development

Beta Development is focused on finalizing the design and preparing for production readiness.

Key activities include:

  • Final design iteration and system optimization
  • Detailed design reviews and documentation audits
  • Manufacturing process development and refinement
  • Build and testing of Beta units/devices
  • Validation of production and testing methods

This phase ensures the device meets technical, regulatory, and market expectations before entering production.

Phase 5: Launch/Pilot Manufacture

The pilot phase is the initial production run—delivering units that are suitable for clinical use or early commercialization.

Key activities include:

  • Full documentation and manufacturing record review
  • Training for internal teams (manufacturing, marketing, service)
  • Refinement of production workflows and throughput
  • Development of custom manufacturing equipment or tooling
  • Integration of automation where appropriate

This phase prepares the system for consistent, scalable production.

Phase 6: Production

Following a successful launch, this phase establishes routine manufacturing operations.

Key activities include:

  • Alignment of production volume with market demand
  • Continuous quality control and process validation
  • Supply chain management and order fulfillment
  • Ongoing product and process optimization

This phase represents sustained serial production and support of the commercial product lifecycle.

Phase 7: Project Close-Out

The final phase focuses on capturing lessons learned and transitioning resources.

Key activities include:

  • Review of project outcomes and performance metrics
  • Documentation of process improvements and feedback
  • Formal release of design and manufacturing teams
  • Archival of all development records for regulatory compliance

This ensures continuous improvement and a clean transition to long-term support or new development programs.

Start Your Project Today

Ready to Take the Next Step?

Whether you're exploring concepts or scaling manufacturing, we're here to help. Use the form to connect with our team—we’ll take it from there.

Please enter your name.
Please enter a message.
Send
Scroll to Top